Table 1. Clinical information of glioma patients.
Patient | Diagnosis | Grade | Age | Sex | IDH type | 1p19q co-deletion | MGMT methylation | Ki-67 (%) | Overall survival (month) |
---|---|---|---|---|---|---|---|---|---|
P1 | Diffuse astrocytoma | II | 42 | M | Wild | Negative | Negative | 4 | 40 |
P2 | Diffuse astrocytoma | II | 34 | M | Wild | Negative | Negative | 5 | 85+ |
P3 | Diffuse astrocytoma | II | 27 | F | Wild | Negative | Negative | 2 | 94+ |
P4 | Anaplastic astrocytoma | III | 36 | M | Wild | Negative | Positive | 10 | 25 |
P5 | Anaplastic astrocytoma | III | 63 | F | Wild | Negative | Positive | 8 | 31 |
P6 | Anaplastic astrocytoma | III | 52 | M | Wild | Negative | Negative | 62+ | 31 |
P7 | Glioblastoma | IV | 63 | M | Wild | Negative | Positive | 30 | 9 |
P8 | Glioblastoma | IV | 27 | M | Wild | Negative | Positive | 30 | 16 |
P9 | Glioblastoma | IV | 39 | F | Wild | Negative | Negative | 20 | 32 |